← Back to Bills
HR 7164118th CongressFailed / ExpiredHouse

Advancing Research for Chronic Pain Act of 2024

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 5, 2025
Latest Action Date
Jan 31, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Advancing Research for Chronic Pain Act of 2024 is a House bill introduced in the 118th Congress aimed at promoting research on chronic pain. The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. There is no official summary or full text available, limiting detailed analysis. The bill falls under the health policy area and appears intended to support scientific investigation into chronic pain conditions.

Bottom Line

This bill sought to enhance research efforts on chronic pain but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce.
  • It is focused on advancing research related to chronic pain, a significant health issue.
  • No official summary or full text is available, restricting detailed understanding of provisions or funding.
Who Benefits?

['Researchers and scientific institutions focused on chronic pain', 'Patients suffering from chronic pain conditions', 'Health agencies involved in pain research and treatment']

Potential Concerns

['Lack of available full text and summary limits transparency on specific provisions and funding mechanisms', 'Unclear oversight and enforcement details due to missing bill text', 'Potential challenges in implementation and resource allocation cannot be assessed']

Political Context

The bill was introduced in the House and referred to the Energy and Commerce Committee, a common step for health-related legislation. It did not advance beyond this referral and was classified as failed or expired. The absence of further legislative action suggests it did not gain sufficient support or priority during the 118th Congress.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have increased federal support for chronic pain research, potentially accelerating development of treatments.', 'Enhanced research funding might have influenced healthcare practices and patient outcomes over time.', 'Failure to pass may have delayed coordinated federal efforts in this health area.']

GovScope Watchdog Notes

The absence of an official summary and full bill text limits transparency and public oversight. Monitoring bills with incomplete public documentation is important to ensure accountability in legislative processes. The bill's failure to advance past committee referral highlights the need for clear communication on legislative priorities and content.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready